ACSL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.030400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.770000E-01
Normal-vs-Stage2
1.975780E-01
Normal-vs-Stage3
9.958600E-01
Normal-vs-Stage4
6.950500E-02
Stage1-vs-Stage2
8.367000E-01
Stage1-vs-Stage3
2.369200E-01
Stage1-vs-Stage4
7.266200E-01
Stage2-vs-Stage3
1.398640E-01
Stage2-vs-Stage4
5.175800E-01
Stage3-vs-Stage4
7.507700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.246800E-01
Normal-vs-AfricanAmerican
1.275990E-01
Normal-vs-Asian
1.706190E-01
Caucasian-vs-AfricanAmerican
3.515000E-01
Caucasian-vs-Asian
3.739200E-01
AfricanAmerican-vs-Asian
8.480600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.120800E-01
Normal-vs-Female
1.904040E-01
Male-vs-Female
4.172800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.503200E-01
Normal-vs-Age(41-60Yrs)
1.246620E-01
Normal-vs-Age(61-80Yrs)
2.455600E-01
Normal-vs-Age(81-100Yrs)
3.232600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.224600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.210000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.979000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.367500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.474600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.987600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.307400E-01
Normal-vs-Daily Drinker
3.044800E-01
Normal-vs-Weekly Drinker
2.962800E-01
Normal-vs-Occasional Drinker
1.403020E-01
Normal-vs-Social Drinker
2.352200E-01
Non Drinker-vs-Daily Drinker
7.585600E-01
Non Drinker-vs-Weekly Drinker
4.623800E-01
Non Drinker-vs-Occasional Drinker
5.442400E-02
Non Drinker-vs-Social Drinker
2.694600E-01
Daily Drinker-vs-Weekly Drinker
6.620600E-01
Daily Drinker-vs-Occasional Drinker
1.339010E-01
Daily Drinker-vs-Social Drinker
4.431200E-01
Weekly Drinker-vs-Occasional Drinker
3.913200E-01
Weekly Drinker-vs-Social Drinker
7.914600E-01
Occasional Drinker-vs-Social Drinker
5.485800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.695500E-02
Normal-vs-Grade 2
2.752000E-02
Normal-vs-Grade 3
2.327700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.835400E-01
Grade 1-vs-Grade 3
4.821000E-01
Grade 1-vs-Grade 4
8.695500E-02
Grade 2-vs-Grade 3
6.897400E-01
Grade 2-vs-Grade 4
2.752000E-02
Grade 3-vs-Grade 4
2.327700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.555000E-01
Normal-vs-NonDiabetic
1.725950E-01
Diabetic-vs-NonDiabetic
7.475800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.839620E-01
Normal-vs-NoPancreatitis
2.420800E-01
Pancreatitis-vs-NoPancreatitis
9.876600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.317550E-01
Normal-vs-N1
2.358600E-01
N0-vs-N1
6.115600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.119810E-01
Normal-vs-TP53-NonMutant
3.530800E-01
TP53-Mutant-vs-TP53-NonMutant
1.171760E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
